You are here
International COVID-19 vaccines recognised by Australia
17 January 2022
Find out which vaccines we recognise for the purpose of travel to Australia.
Check this page regularly to stay up to date. Advice may change.
We approve COVID-19 vaccines for use in Australia. This includes checking if they meet our high safety, quality and effectiveness standards.
We also recognise some vaccines that are used in other countries, but not approved for use in Australia.
Vaccines we've approved for use in Australia
We recognise all vaccines that are provisionally approved for use in Australia for incoming travellers. These include:
- Comirnaty (Pfizer)
- Vaxzevria (AstraZeneca)
- Spikevax or Takeda (Moderna)
- COVID-19 Vaccine Janssen (Janssen).
Need more information about our approval process? Find out how we assess COVID-19 vaccines.
Vaccines we recognise for the purpose of travel to Australia
As of 17 January 2022, we recognise the following vaccines for the purpose of travel to Australia:
- Coronavac (Sinovac)
- Covishield (AstraZeneca - Serum Institute of India)
- BBIBP-CorV for people under 60 years of age on arrival in Australia (Sinopharm China)
- Covaxin (Bharat Biotech)
- Sputnik V (Gamaleya Research Institute)
Travelling to Australia?
Read What I need to do before I travel on the Department of Home Affairs website and COVID-19 vaccinations on smartraveller.gov.au.
Download our reports
Need more detailed information?
- Summary report from 17 January 2022: COVID-19 vaccines not registered in Australia but in current international use - TGA advice on 'recognition' (pdf,2Mb)
- Summary report from 1 November 2021: COVID-19 vaccines not registered in Australia but in current international use - TGA advice on 'recognition' (pdf,183kb)
- Full report from 27 September 2021: COVID-19 vaccines not registered in Australia but in current international use - TGA advice on 'recognition' (1.6Mb)